These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 22584330)

  • 1. [Promising new injection method to prevent angialgia/phlebitis from epirubicin hydrochloride therapy for breast cancer].
    Ono C; Yamagami M; Kamatani R; Yamamoto M; Mukouyama T; Sugimoto M; Suzuki T; Kamo N; Seki N; Eguchi K; Ikeda T
    Gan To Kagaku Ryoho; 2012 May; 39(5):777-81. PubMed ID: 22584330
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevention of venous pain and phlebitis caused by epirubicin hydrochloride.
    Sugimoto M; Matsui M; Harada M; Yamauchi Y; Moriyama N; Andou K; Yamamoto M; Yamaoka H; Ono C; Ishikawa M; Kamo N; Ikeda T; Yamaoka K
    Gan To Kagaku Ryoho; 2009 Jun; 36(6):969-74. PubMed ID: 19542717
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Improvement of epirubicin-induced phlebitis to switch from liquid preparation to lyophilized formulation].
    Suga Y; Kumazaki M; Nishigami J; Takeda K; Kawagishi A; Ishizaki J; Inokuchi M; Miyamoto K; Arai K
    Gan To Kagaku Ryoho; 2009 Jan; 36(1):93-6. PubMed ID: 19151570
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Change of formulation decreases venous irritation in breast cancer patients receiving epirubicin.
    Nagata K; Egashira N; Yamada T; Watanabe H; Yamauchi Y; Oishi R
    Support Care Cancer; 2012 May; 20(5):951-5. PubMed ID: 21519948
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epirubicin chemotherapy in women with breast cancer: Alternating arms for intravenous administration to reduce chemical phlebitis.
    Roberts R; Hanna L; Borley A; Dolan G; Williams EM
    Eur J Cancer Care (Engl); 2019 Sep; 28(5):e13114. PubMed ID: 31148328
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytotoxic and antiproliferative activity of the single agent epirubicin versus epirubicin plus tamoxifen as primary chemotherapy in human breast cancer: a single-institution phase III trial.
    Bottini A; Berruti A; Brizzi MP; Bersiga A; Generali D; Allevi G; Aguggini S; Bolsi G; Bonardi S; Tondelli B; Vana F; Tampellini M; Alquati P; Dogliotti L
    Endocr Relat Cancer; 2005 Jun; 12(2):383-92. PubMed ID: 15947110
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interim Analysis of a Phase II study of epirubicin and paclitaxel as first-line therapy in patients with metastatic breast cancer.
    Luck HJ; Thomssen C; duBois A; Lisboa BW; Untch M; Kuhnle H; Konecny G; Janicke F; Meerpohl HG; Lindner C; Hecker D; Diergarten K
    Semin Oncol; 1996 Feb; 23(1 Suppl 1):33-6. PubMed ID: 8629034
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A dose-finding study of epirubicin in combination with paclitaxel in the treatment of advanced breast cancer.
    Conte PF; Michelotti A; Baldini E; Salvadori B; Gennari A; Da Prato M; Tibaldi C; Salzano E; Gentile A
    Semin Oncol; 1996 Oct; 23(5 Suppl 11):28-31. PubMed ID: 8893896
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Neoadjuvant intraarterial chemotherapy with dose intensification in locally advanced breast cancer].
    Takatsuka Y; Shin E; Fukuda K; Mishima H; Tono T; Yagyuu T; Kobayashi K; Kikkawa N
    Gan To Kagaku Ryoho; 1995 Sep; 22(11):1546-8. PubMed ID: 7574755
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Intra-arterial infusion chemotherapy in the treatment of advanced breast cancer--doxorubicin versus epirubicin].
    Yayoi E; Furukawa J; Takatsuka Y; Kobayashi T; Aikawa T; Maeura Y; Kaji M; Kotsuma Y
    Gan To Kagaku Ryoho; 1992 Aug; 19(10 Suppl):1621-4. PubMed ID: 1530320
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Comparative study of chemosensitivity and efficacy between pirarubicin and epirubicin in breast cancer].
    Zang MF; Zhang YM; Zhi YH; Zhai Z; Zhang M; Gu F; Zhi XC
    Zhonghua Yi Xue Za Zhi; 2011 May; 91(20):1388-92. PubMed ID: 21756809
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Evaluation of two different regimens as neoadjuvant chemotherapy for breast cancer].
    Yang D; Tong F; Cao Y; Liu P; Zhou B; Liu H; Qiao X; Zhang J
    Zhonghua Zhong Liu Za Zhi; 2002 May; 24(3):303-5. PubMed ID: 12515634
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Efficacy of activated charcoal-epirubicin suspension for treatment of breast cancer with axillary metastasis].
    Wu WJ; Zeng J; Pan CE
    Nan Fang Yi Ke Da Xue Xue Bao; 2006 Dec; 26(12):1812-4. PubMed ID: 17259127
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Vasculitic condition following instillation of epirubicin hydrochloride in an outpatient chemotherapy].
    Nakazawa Y; Matsubara Y; Suzuki M; Asako E; Honda A
    Gan To Kagaku Ryoho; 2005 Dec; 32 Suppl 1():24-6. PubMed ID: 16422479
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Images in clinical medicine. Extravasation of epirubicin.
    Vano-Galvan S; Jaen P
    N Engl J Med; 2009 May; 360(20):2117. PubMed ID: 19439746
    [No Abstract]   [Full Text] [Related]  

  • 16. A case of manic episode during treatment with 5-fluorouracil, epirubicin and cyclophosphamide for breast cancer.
    Pacchiarotti I; Mazzarini L; Pellegrini P; Venturelli V; Sani G; Sánchez-Moreno J; Mancinelli I; Tatarelli R; Kotzalidis GD; Girardi P
    Gen Hosp Psychiatry; 2007; 29(5):461-3. PubMed ID: 17888816
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tropisetron in the prevention of acute nausea and vomiting in patients treated with high dose epirubicin.
    Nicolaides C; Giannakakis T; Skarlos D; Athanassiadis A; Fountzilas G; Damigos D; Pavlidis N
    J Exp Clin Cancer Res; 1998 Mar; 17(1):71-5. PubMed ID: 9646236
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epirubicin-vinorelbine vs FEC100 for node-positive, early breast cancer: French Adjuvant Study Group 09 trial.
    Kerbrat P; Roché H; Bonneterre J; Veyret C; Lortholary A; Monnier A; Fumoleau P; Fargeot P; Namer M; Chollet P; Goudier MJ; Audhuy B; Simon H; Montcuquet P; Eymard JC; Walter S; Clavère P; Guastalla JP;
    Br J Cancer; 2007 Jun; 96(11):1633-8. PubMed ID: 17505516
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of prophylactic treatment with intravesical epirubicin on recurrence of superficial bladder cancer--The 6th Trial of the Japanese Urological Cancer Research Group (JUCRG): a randomized trial of intravesical epirubicin at dose of 20mg/40ml, 30mg/40ml, 40mg/40ml.
    Kuroda M; Niijima T; Kotake T; Akaza H; Hinotsu S;
    Eur Urol; 2004 May; 45(5):600-5. PubMed ID: 15082202
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Usefulness of ambulatory adjuvant chemotherapy with low-dose epirubicin in patients with axially-node positive breast cancer: Chiba Epirubicin Cooperative Study Group].
    Miyauchi M; Yamamoto N; Nakajima N; Suzuki M; Takahashi M; Ohno K; Ogawa K; Tsukamoto T; Yamamoto K; Oheda Y;
    Gan To Kagaku Ryoho; 2001 Jan; 28(1):43-8. PubMed ID: 11201379
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.